FEops is a revolutionary brand that is dedicated to transforming personalized treatment for patients with structural heart disease. They achieve this by combining unique digital twins and AI-enabled anatomical analysis technologies, uncovering data-driven insights for procedure planning and periprocedural guidance that were previously unprecedented. By working with a team of passionate individuals who are committed to supporting physicians and improving patient outcomes, FEops empowers healthcare professionals to enhance both procedure efficiency and clinical outcomes.

Furthermore, FEops collaborates with healthcare companies to expedite the development and launch of superior products into the market. Led by co-founders Matthieu De Beule (CEO) and Peter Mortier (CTO), along with a team of experienced professionals, FEops continues to revolutionize the medtech sector. With their innovative ideas and groundbreaking work, they are paving the way for a new era in the transcatheter structural heart procedures